KEY TAKEAWAY: Facebook wants pharma money and they want it for everything from advertising new drugs to clinical trials but obstacles still remain. Continue reading
KEY TAKEAWAY: Consumers and patients do not want to have a social media relationship with a pharma company. I heard this again and again during the course of three years research for clients. Facebook just doesn’t understand what people want from pharma. Continue reading
POST SUMMARY: While the majority of pharma companies await social media marketing guidelines, consumers are pretty much ignoring brands on the channel. This means that biopharma marketers are going to have to work extra hard to make social media a viable channel to reach patients and consumers. Continue reading
It looks like the shine is starting to come off the number one social media site in the world, Facebook. Now comes word in a big shift from the stance Facebook took a year ago, when agencies called out the fact that posts published by clients were being seen by fewer of their fans, that marketers are going to have to pay for reach on Facebook via ads as organic posts are seen by less than 1% of users. Is this a sign that social media doesn’t hold promise for pharma marketers ? No, not at all. It’s a sign that you need to better understand your patients and the channels they use to get health information and make decisions.